-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Zura Bio, Lowers Price Target to $10

Benzinga·11/09/2026 17:28:33
Listen to the news
Wedbush analyst Martin Fan maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $22 to $10.